Imago BioSciences stock soars after Merck bids more than 100% premium to buy the biotech
Shares of Imago BioSciences Inc. soared toward an eight-month high in premarket trading Monday, after the biopharmaceutical company developing treatments for myeloproliferative neoplasms (MPNs) and...